General MedicationsINJECTIONStandard
DEXAMETHASONE SODIUM PHOSPHATE
DEXAMETHASONE SODIUM PHOSPHATE
Standard Dose
EQ 10MG PHOSPHATE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Key Takeaways
- Primary indication: Review priority: STANDARD Marketing status: Prescription
- Approval overview DEXAMETHASONE SODIUM PHOSPHATE is listed in Drugs@FDA under application 217797 (ANDA).
- Review priority: STANDARD Marketing status: Prescription Active ingredient DEXAMETHASONE SODIUM PHOSPHATE Form and strength INJECTABLE;INJECTION - EQ 10MG PHOSPHATE/ML Sponsor MICRO LABS Submission history Latest submission status date: 2025-07-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview DEXAMETHASONE SODIUM PHOSPHATE is listed in Drugs@FDA under application 217797 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DEXAMETHASONE SODIUM PHOSPHATE Form and strength INJECTABLE;INJECTION - EQ 10MG PHOSPHATE/ML Sponsor MICRO LABS Submission history Latest submission status date: 2025-07-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.